Standard BioTools Return on Tangible Equity 2010-2024 | LAB
Current and historical return on tangible equity values for Standard BioTools (LAB) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Standard BioTools Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-09-30 |
$-0.17B |
$0.36B |
-55.12% |
| 2024-06-30 |
$-0.17B |
$0.38B |
-69.47% |
| 2024-03-31 |
$-0.14B |
$0.45B |
-83.05% |
| 2023-12-31 |
$-0.08B |
$0.06B |
-97.72% |
| 2023-09-30 |
$-0.08B |
$0.07B |
-83.75% |
| 2023-06-30 |
$-0.08B |
$0.09B |
-79.81% |
| 2023-03-31 |
$-0.13B |
$0.10B |
-108.04% |
| 2022-12-31 |
$-0.19B |
$0.11B |
-273.38% |
| 2022-09-30 |
$-0.18B |
$0.13B |
-560.63% |
| 2022-06-30 |
$-0.16B |
$0.15B |
1715.79% |
| 2022-03-31 |
$-0.12B |
$-0.11B |
212.84% |
| 2021-12-31 |
$-0.06B |
$-0.04B |
181.54% |
| 2021-09-30 |
$-0.07B |
$-0.04B |
277.55% |
| 2021-06-30 |
$-0.06B |
$-0.03B |
421.05% |
| 2021-03-31 |
$-0.06B |
$-0.02B |
497.78% |
| 2020-12-31 |
$-0.05B |
$-0.01B |
572.97% |
| 2020-09-30 |
$-0.05B |
$0.00B |
738.46% |
| 2020-06-30 |
$-0.06B |
$-0.02B |
1100.00% |
| 2020-03-31 |
$-0.06B |
$-0.01B |
-1400.00% |
| 2019-12-31 |
$-0.07B |
$0.00B |
-490.57% |
| 2019-09-30 |
$-0.07B |
$0.01B |
687.18% |
| 2019-06-30 |
$-0.07B |
$0.02B |
145.26% |
| 2019-03-31 |
$-0.07B |
$0.02B |
83.78% |
| 2018-12-31 |
$-0.06B |
$-0.09B |
48.76% |
| 2018-09-30 |
$-0.05B |
$-0.14B |
40.22% |
| 2018-06-30 |
$-0.06B |
$-0.13B |
41.43% |
| 2018-03-31 |
$-0.06B |
$-0.12B |
40.51% |
| 2017-12-31 |
$-0.06B |
$-0.14B |
41.74% |
| 2017-09-30 |
$-0.07B |
$-0.14B |
48.23% |
| 2017-06-30 |
$-0.07B |
$-0.15B |
52.65% |
| 2017-03-31 |
$-0.07B |
$-0.14B |
59.44% |
| 2016-12-31 |
$-0.08B |
$-0.13B |
68.75% |
| 2016-09-30 |
$-0.07B |
$-0.12B |
72.54% |
| 2016-06-30 |
$-0.06B |
$-0.11B |
69.32% |
| 2016-03-31 |
$-0.06B |
$-0.09B |
72.61% |
| 2015-12-31 |
$-0.05B |
$-0.08B |
75.18% |
| 2015-09-30 |
$-0.05B |
$-0.07B |
79.07% |
| 2015-06-30 |
$-0.06B |
$-0.07B |
93.72% |
| 2015-03-31 |
$-0.05B |
$-0.06B |
97.30% |
| 2014-12-31 |
$-0.05B |
$-0.06B |
101.92% |
| 2014-09-30 |
$-0.05B |
$-0.06B |
335.71% |
| 2014-06-30 |
$-0.04B |
$-0.05B |
-154.17% |
| 2014-03-31 |
$-0.03B |
$-0.05B |
-45.90% |
| 2013-12-31 |
$-0.02B |
$0.10B |
-17.39% |
| 2013-09-30 |
$-0.02B |
$0.10B |
-16.16% |
| 2013-06-30 |
$-0.02B |
$0.10B |
-15.92% |
| 2013-03-31 |
$-0.02B |
$0.10B |
-19.26% |
| 2012-12-31 |
$-0.02B |
$0.10B |
-26.23% |
| 2012-09-30 |
$-0.02B |
$0.10B |
-29.12% |
| 2012-06-30 |
$-0.02B |
$0.05B |
-35.02% |
| 2012-03-31 |
$-0.02B |
$0.05B |
-36.52% |
| 2011-12-31 |
$-0.03B |
$0.06B |
-50.20% |
| 2011-09-30 |
$-0.03B |
$0.06B |
-12400.00% |
| 2011-06-30 |
$-0.03B |
$0.06B |
200.00% |
| 2011-03-31 |
$-0.03B |
$0.07B |
91.80% |
| 2010-12-31 |
$-0.02B |
$-0.19B |
35.60% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.529B |
$0.106B |
|
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|
